Prosecutors seek to gag 'Pharma Bro' Martin Shkreli in criminal case
Former drug company CEO notorious for raising price of life-saving treatment by 5,000 per cent
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Prosecutors want a judge to make “Pharma Bro” Martin Shkreli stop talking and filed a motion on Monday asking that he and all attorneys in his criminal case be ordered to refrain from making any statements outside court.
Shkreli, a former pharmaceutical company CEO most notorious for raising the price of a lifesaving drug by 5,000 per cent while at another company, is on trial for charges of federal securities fraud.
In the motion, federal prosecutors told US District Court Judge Kiyo Matsumoto that Shkreli has interacted with the media since the jury for his trial was picked, in the courthouse, outside and on digital media. They said his statements risk tainting the jury.
“Shkreli appears determined to ignore the instructions of defence counsel and to wage his own public relations campaign against the witnesses and the government during the trial,” prosecutors said.
Defence attorney Benjamin Brafman objected to a gag order and said “certain representatives of the press have gone out of their way to try to 'bait”' Shkreli into making public statements. He said his client is “under enormous pressure that is compounded by his clearly frail emotional state.”
Prosecutors said another alternative could be for the judge to semi-sequester the jury.
Shkreli became notorious in 2015 when a drug company he founded, Turing Pharmaceuticals, spent $55 million for a lifesaving medicine called Daraprim and then increased the price from $13.50 to $750 per pill.
He was arrested later that year on unrelated charges, centring around a pair of failed hedge funds. He has pleaded not guilty.
Associated Press
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments